Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000533145 | SCV000642191 | likely benign | Familial focal epilepsy with variable foci | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001200451 | SCV001371421 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | DEPDC5: BS1 |
Gene |
RCV001200451 | SCV001837970 | benign | not provided | 2019-05-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456135 | SCV002614168 | likely benign | Inborn genetic diseases | 2022-06-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001200451 | SCV001928041 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001200451 | SCV001967916 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003935460 | SCV004750337 | likely benign | DEPDC5-related disorder | 2020-09-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |